VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
Go back to VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.80 +0.03 (3.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $5.86 | |||
| Open | $0.82 | 52 Week Low | $3.05 | |||
| Day High | $0.83 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $-0.45 | |||
| Volume | 810,367 | |||||
